Grace Therapeutics, Inc. Common Stock (GRCE)

Typically moves ±3.79% on earnings

EARNINGS ANALYTICS

event_upcoming Next Earnings: 2026-11-13 HIGH CONFIDENCE

Across 21 earnings reports since Jun 22, 2021, Grace Therapeutics, Inc. Common Stock (GRCE) has a clear post-earnings pattern. It moves ±3.79% on average after reporting and finishes higher 61.9% of the time. Its largest post-earnings gain was +12.92% (Jun 22, 2021) and its largest decline was -10.21% (Nov 13, 2023). The next earnings report is predicted for 2026-11-13 (high confidence).

Earnings reactions

How GRCE moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±3.79%

Positive %

61.9%

Negative %

38.1%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Jun 18, 2026	☀ PRE	+6.52%	open_in_new
Feb 12, 2026	☀ PRE	-1.67%	open_in_new
Nov 13, 2025	☀ PRE	-0.16%	open_in_new
Aug 12, 2025	☀ PRE	+1.6%	open_in_new
Jun 23, 2025	☀ PRE	-1.16%	open_in_new
Feb 13, 2025	☀ PRE	+2.65%	open_in_new
Nov 13, 2024	☀ PRE	+0%	open_in_new
Aug 09, 2024	☀ PRE	-4.61%	open_in_new
Jun 21, 2024	☀ PRE	+4.84%	open_in_new
Feb 12, 2024	☀ PRE	+10.13%	open_in_new
Nov 13, 2023	☀ PRE	-10.21%	open_in_new
Aug 11, 2023	☀ PRE	-2.88%	open_in_new
Jun 23, 2023	☀ PRE	+0%	open_in_new
Feb 14, 2023	☀ PRE	+3.16%	open_in_new
Nov 14, 2022	☀ PRE	+2.9%	open_in_new
Aug 11, 2022	☀ PRE	+4%	open_in_new
Jun 21, 2022	☀ PRE	+5.24%	open_in_new
Feb 14, 2022	☀ PRE	+2.54%	open_in_new
Nov 10, 2021	☀ PRE	-2.06%	open_in_new
Aug 12, 2021	☽ POST	-0.38%	open_in_new
Jun 22, 2021	☀ PRE	+12.92%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±3.79%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 4 →

Funds holding

$2322959

Total value held

Buying

3 added · 1 reduced

Bank Of America Corp /De/

$2290568 +0.01%

Morgan Stanley

$21057 -82.13%

Wells Fargo & Company/Mn

$8334 NEW BUY

Royal Bank Of Canada

$3000 NEW BUY

SEC Filing Types

description SCHEDULE 13G/A

1 chevron_right

Recent SEC Filings

5 most recent

Form	Date Filed	View on EDGAR
10-K	20260618	open_in_new SEC.gov
8-K	20260618	open_in_new SEC.gov
8-K	20260618	open_in_new SEC.gov
8-K	20260605	open_in_new SEC.gov
SCHEDULE 13G/A	20260515	open_in_new SEC.gov

Frequently asked about GRCE earnings

When does Grace Therapeutics, Inc. Common Stock report earnings next? expand_more

Grace Therapeutics, Inc. Common Stock (GRCE)'s next earnings date is predicted (high confidence) for 2026-11-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does GRCE stock move after earnings? expand_more

Over 21 reports, GRCE has moved an average of ±3.79% the session after earnings, closing higher 61.9% of the time.

What was GRCE's biggest post-earnings move? expand_more

GRCE's largest post-earnings gain on record was +12.92% on Jun 22, 2021, and its largest decline was -10.21% on Nov 13, 2023.

Where can I find Grace Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Grace Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.